Use of medicines in special conditions: Real-world treatment outcomes in a tertiary hospital

被引:0
|
作者
Giraldo Pena, A. [1 ]
Munoz Bolano, M. [1 ]
Rodriguez Cumplido, D. [1 ]
Ruiz Batuecas, E. [1 ]
Comas Sugranes, M. [1 ]
Ferrer Artola, A. M. [1 ]
Llop Rius, R. [1 ]
机构
[1] Hosp Univ Bellvitge, Lhospitalet De Llobregat, Spain
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
30
引用
收藏
页码:51 / 51
页数:1
相关论文
共 50 条
  • [21] PRESCRIPTION PATTERNS OF ANTIHYPERTENSIVE MEDICINES IN CHINA: A DESCRIPTIVE ANALYSIS IN REAL-WORLD CONDITIONS
    Li, L.
    Liu, D.
    Xie, X.
    Dong, P.
    Lin, Y.
    VALUE IN HEALTH, 2017, 20 (05) : A278 - A278
  • [22] Real-world use of telavancin in the treatment of osteomyelitis
    Saravolatz, Louis D.
    Cleveland, Kerry O.
    Rikabi, Khalid
    Hassoun, Ali
    Reilly, Joseph
    Johnson, Leonard B.
    Spak, Cedric
    Valenti, Sharon
    Szpunar, Susan
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2019, 95 (02) : 185 - 190
  • [23] Real-World Use of Oritavancin for the Treatment of Osteomyelitis
    Scoble, Patrick J.
    Reilly, Joseph
    Tillotson, Glenn S.
    DRUGS-REAL WORLD OUTCOMES, 2020, 7 (Suppl 1) : 46 - 54
  • [24] Real-World Use of Oritavancin for the Treatment of Osteomyelitis
    Patrick J. Scoble
    Joseph Reilly
    Glenn S. Tillotson
    Drugs - Real World Outcomes, 2020, 7 : 46 - 54
  • [25] Outcomes of "Real-World" Insulin Strategies in the Management of Hospital Hyperglycemia
    Sadhu, Archana R.
    Patham, Bhargavi
    Vadhariya, Aisha
    Chikermane, Soumya G.
    Johnson, Michael L.
    JOURNAL OF THE ENDOCRINE SOCIETY, 2021, 5 (08)
  • [26] REAL-WORLD OUTCOMES AFTER VEDOLIZUMAB DISCONTINUATION IN A TERTIARY IBD COHORT
    Sebepos-Rogers, Gregory
    Fragkos, Konstantinos
    Saravanapavan, Hajeena
    Barragry, John
    Koo, Hui Fen
    Ko, Ho Juen
    Parisi, Ioanna
    Seward, Edward
    McCartney, Sara
    Bloom, Stuart
    Mehta, Shameer
    Rahman, Farooq
    GUT, 2021, 70 : A81 - A82
  • [27] Tumor stage and primary treatment of hepatocellular carcinoma at a large tertiary hospital in China: A real-world study
    Zhong, Jian-Hong
    Peng, Ning-Fu
    You, Xue-Mei
    Ma, Liang
    Xiang, Xiao
    Wang, Yan-Yan
    Gong, Wen-Feng
    Wu, Fei-Xiang
    Xiang, Bang-De
    Li, Le-Qun
    ONCOTARGET, 2017, 8 (11) : 18296 - 18302
  • [28] Real-World treatment outcomes for advanced NSCLC in Greece
    Kokkotou, Eleni
    Stournara, Lamprini
    Mani, Maria
    Gkiozos, Ioannis
    Tsagouli, Sofia
    Syrigos, Nikolaos
    Burke, Thomas
    Desiniotis, Andreas
    Dimitriadis, Ioannis
    Charpidou, Andriani
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [29] Real-World Outcomes of Ruxolitinib Treatment for Polycythemia Vera
    Coltoff, Alexander
    Mesa, Ruben
    Gotlib, Jason
    Shulman, Jessica
    Rampal, Raajit K.
    Siwoski, Olivia
    Yacoub, Abdulraheem
    Moliterno, Alison
    Yang, Anna
    Braunstein, Evan
    Gerds, Aaron T.
    Hobbs, Gabriela S.
    Winton, Elliott F.
    Goel, Swati
    Wadleigh, Martha
    Tremblay, Douglas
    Moshier, Erin
    Mascarenhas, John
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (10): : 697 - +
  • [30] Real-world Management of CML: Outcomes and Treatment Patterns
    Held, Nicole
    Atallah, Ehab L. L.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2023, 18 (05) : 167 - 175